Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values-Reference-Cited by-同舟云学术

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values

Published:2015-08 Issue:4 Volume:82 Page:303-313
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Pfaller M.A.,Rhomberg P.R.,Messer S.A.,Jones R.N.,Castanheira M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference72 articles.

1. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations;Alexander;Clin Infect Dis,2013

2. National surveillance of fungemia in Denmark (2004 to 2009);Arendrup;J Clin Microbiol,2011

3. Differential in vivo activity of anidulafungin, caspofungin and micafungin against C. glabrata with and without FKS resistance mutations;Arendrup;Antimicrob Agents Chemother,2012

4. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme;Arendrup;Clin Microbiol Infect,2013

5. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia;Beyda;Clin Infect Dis,2014

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cluster analysis allowed to identify antifungal drugs that retain efficacy against Candida albicans isolated from patients with inflammatory diseases of the soft tissues of the maxillofacial area;Frontiers in Oral Health;2024-09-06

2. Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens;Medical Mycology;2024-06

3. In vitro antifungal activity, cytotoxicity and binding analysis of imidazolium based ionic liquids with fluconazole: DFT and spectroscopic study;Journal of Molecular Liquids;2024-05

4. Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021);Journal of Clinical Microbiology;2024-02-14

5. Antifungal Resistance and Genotyping of Clinical Candida parapsilosis Complex in Japan;Journal of Fungi;2023-12-20